Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Linio Biotech logo — Redefining skin regeneration

Linio Biotech

Redefining skin regeneration

Founded 2017 Finland Finland 21 employees Seed Total: $9.30M Biotechnology, Life Sciences

General Information

Company Name Linio Biotech
Founded Year 2017
Location Finland Finland
Employees 21
Industries Biotechnology, Life Sciences
Funding Stage Seed
Business Model B2B, B2D, B2C
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Linio Biotech. To contact Linio Biotech, visit linio-biotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Linio Biotech compare?

A PDF of Linio Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Linio Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Linio Biotech

Linio Biotech, founded in 2017, is spearheading innovation in the Biotechnology and Life Sciences industries with its proprietary Tience® technology. This Finland-based company aims to redefine aesthetic medicine through the development of groundbreaking regenerative injectables, promising a shift away from temporary fillers and invasive procedures.

Dedicated to natural tissue augmentation, Linio Biotech delivers a product that is both safe and biologically active, fostering sustainable and natural tissue regeneration. The company's flagship technology is already commercialized in the Nordics, backed by clinical research and substantial real-world data. With a recent early-stage investment of €4.20M, Linio Biotech is poised to extend its innovative solutions globally, presenting a compelling opportunity for investors looking at next-gen solutions in aesthetic healthcare.

Business keywords: Regenerative Medicine, Tissue Engineering, Aesthetic Medicine, Injectable Tissue Augmentation, Biotechnology Platform, Cell-Free Tissue Products, Skin Defect Treatment, Aged Skin Solutions, Proprietary Technology, Clinical Research, Biologically Active Products, Sustainable Regeneration, Dermatology Solutions, Innovative R&D

Services & Products

Development of regenerative medical devices
Injectable natural tissue augmentation
Research and development in regenerative aesthetics

Target Customers

Aesthetic medicine practitioners Patients seeking non-invasive aesthetic treatments Medical professionals focused on skin and soft tissue restoration

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC €4.20M -
01 Nov 2023
Grant €1.00M -
01 May 2023
Seed €4.10M -
01 Jul 2021
Spinout Undisclosed 1
Tampere University
01 Jan 2017

Linio Biotech Alternatives & Competitors

View All Alternatives
Linio Biotech vs
BioTissue SA
BioTissue SA Switzerland

Pioneers of Tissue Engineering and Regenerative Medicine

3 employees
Biotechnology, Health Care
Linio Biotech vs
Foldink
Foldink United States

Biotechnology company that is creating bioinks for 3D bioprinting, an advanced method for tissue eng...

16 employees
Biotechnology, Life Sciences
Linio Biotech vs
Qkine
Qkine United Kingdom

High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and...

Series B
40 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Linio Biotech

Redefining skin regeneration
Linio Biotech was founded in 2017.
Linio Biotech is headquartered in Finland.
Linio Biotech operates in Biotechnology and Life Sciences. Its work centres on Regenerative Medicine, Tissue Engineering, Aesthetic Medicine and Injectable Tissue Augmentation. Its customers include Aesthetic medicine practitioners, Patients seeking non-invasive aesthetic treatments and Medical professionals focused on skin and soft tissue restoration.
Linio Biotech has a B2B, B2D and B2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Linio Biotech has approximately 21 employees.
Linio Biotech has completed 4 funding rounds, raising a total of $9.30M. The latest funding stage is Seed.
Linio Biotech offers: Development of regenerative medical devices, Injectable natural tissue augmentation, Research and development in regenerative aesthetics.
Top alternatives and competitors to Linio Biotech include BioTissue SA, Foldink, Qkine, Aspect Biosystems, CytoNiche. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Linio Biotech and BioTissue SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Linio Biotech, https://bouncewatch.com/company/linio-biotech, updated 13 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout